Wellbiotec Co., Ltd. Stock

Equities

A010600

KR7010600005

Textiles & Leather Goods

End-of-day quote Korea S.E. 06:00:00 2024-04-04 pm EDT 5-day change 1st Jan Change
545 KRW -6.84% Intraday chart for Wellbiotec Co., Ltd. -.--% -54.77%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2022 158B 116M Sales 2023 72.13B 52.73M Capitalization 110B 80.09M
Net income 2022 -20.88B -15.26M Net income 2023 -64.91B -47.45M EV / Sales 2022 0.39 x
Net cash position 2022 8.47B 6.19M Net cash position 2023 13.12B 9.59M EV / Sales 2023 1.34 x
P/E ratio 2022
-3.28 x
P/E ratio 2023
-1.47 x
Employees 29
Yield 2022 *
-
Yield 2023
-
Free-Float 87.31%
More Fundamentals * Assessed data
Dynamic Chart
Wellbiotec Co., Ltd.(KOSE:A010600) dropped from S&P Global BMI Index CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Wellbiotec Co., Ltd. announced that it has received KRW 8.00000001 billion in funding from K-Impact Fund CI
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Wellbiotec Co., Ltd. announced that it has received KRW 3 billion in funding from KH Feelux Co., Ltd. CI
Wellbiotec Co., Ltd. announced that it has received KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm CI
Wellbiotec Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm CI
KOSSEN Co., Ltd. cancelled the acquisition of additional 14.57% stake in Biogenicskorea Co., Ltd. from a group of sellers. CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Wellbiotec Co., Ltd. announced that it expects to receive KRW 3 billion in funding from KH Feelux Co., Ltd. CI
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day-6.84%
3 months-39.91%
6 months-63.84%
Current year-54.77%
More quotes
Current year
519.00
Extreme 519
1 237.00
1 year
519.00
Extreme 519
5 200.00
3 years
519.00
Extreme 519
5 200.00
5 years
519.00
Extreme 519
5 440.00
10 years
519.00
Extreme 519
10 950.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 18-07-16
Comptroller/Controller/Auditor 53 -
Members of the board TitleAgeSince
Chief Executive Officer 50 18-07-16
Director/Board Member 57 18-11-14
Director/Board Member 52 -
More insiders
WELLBIOTEC CO.,LTD, formerly YBROAD CO., LTD., is a Korea-based company engaged in the leather business. The Company’s products portfolio consists of nappa, naked, soft and other types of leathers used for handbags; water proof, gore-tex, nubuck, white and washable leathers used for shoes; chrome and non-chrome leathers used for car seats; chrome and non-chrome, and grain leathers used for steering wheels, and others, including baseball glove leathers and belt leathers. It also involves in the integrated transportation business, as well as wholesale and retail of electrical equipment business through its subsidiaries. The Company supplies its leather products to Coach, Tumi, Juicy, Vicotornox, Brighton, Timberland, Foot Joy, Stride Rite, Honda, Acura, Suzuki, Toyota and others.
More about the company
  1. Stock Market
  2. Equities
  3. A010600 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW